Income statement
USD
Annual
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 62M | 52M | 37M | 37M | 29M |
| Gross Profit | 16M | 16M | 8M | 8M | 9M |
| Operating Income | 2M | 5M | -4M | -2M | 3M |
| EBITDA | 4M | 6M | -3M | -2M | 4M |
| Net Income | 2M | 4M | -4M | -3M | 2M |
| EPS (Diluted) | — | — | — | — | — |
Consumer Defensive
Live Price
Offline$1.34
+4.69% today
1Y Change
-74.23%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Solesence, Inc. Common Stock (SLSN) is a Consumer Defensive stock with a market cap of $90.00M and listed on NASDAQ. The stock last traded around $1.34 and down 74.2% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +18.6%, EPS growth of -57.1%, a dividend yield of 0.0%. What stands out right now is revenue +18.6%, EPS -57.1%, free cash flow -314.0% with operating margin 2.5% and ROIC 3.6%. Valuation already assumes a fairly strong business story at P/E 52.8 and price/sales 1.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SLSN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SLSN
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SLSN Max Drawdown
-84.42%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SLSN and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$29.5M
-21.0% YoY
FY Net Income
$2.3M
+188.4% YoY
Free Cash Flow
$447.0K
+110.0% YoY
Revenue Growth
+18.6%
EPS Growth
-57.1%
Gross Margin
25.9%
Net Margin
2.9%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 62M | 52M | 37M | 37M | 29M |
| Gross Profit | 16M | 16M | 8M | 8M | 9M |
| Operating Income | 2M | 5M | -4M | -2M | 3M |
| EBITDA | 4M | 6M | -3M | -2M | 4M |
| Net Income | 2M | 4M | -4M | -3M | 2M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1M | 1M | 2M | 2M | 657K |
| Total Assets | 50M | 50M | 33M | 34M | 28M |
| Total Liabilities | 32M | 35M | 31M | 28M | 21M |
| Shareholder Equity | 18M | 15M | 2M | 6M | 7M |
| Total Debt | 24M | 15M | 21M | 18M | 15M |
| Net Debt | 23M | 14M | 20M | 16M | 14M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
2M
+240.7% YoY
Capital Expenditures
2M
+33.6% YoY
Free Cash Flow
447K
+110.0% YoY
Key ratios
Gross Margin
25.9%
Operating Margin
2.5%
Net Margin
2.9%
ROE
10.5%
Debt / Equity
1.38x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.